Deutsche Bank Ag\ Citius Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $0.86 $56,180 - $74,330	86,431 New	86,431 $65,000
Q2 2022 Aug 11, 2022	SELL	$0.88 - $1.87 $54,187 - $115,148	-61,577 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.38 - $1.89 $10,189 - $13,955	-7,384 Reduced 10.71%	61,577 $110,000
Q4 2021 Feb 11, 2022	BUY	$1.51 - $2.2 $5,508 - $8,025	3,648 Added 5.59%	68,961 $106,000
Q3 2021 Nov 04, 2021	SELL	$1.74 - $2.6 $3,657 - $5,465	-2,102 Reduced 3.12%	65,313 $133,000
Q2 2021 Aug 11, 2021	BUY	$1.51 - $4.23 $101,796 - $285,165	67,415 New	67,415 $235,000
Q4 2018 Feb 14, 2019	SELL	$0.99 - $1.89 $210 - $402	-213 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.14 - $3.09 $242 - $658	213 New	213 $0

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $457M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.